Qiri

Platform

Pharmacist consoleThe queue, the trace, the sign-off Specialist intelligenceSix specialists, as each script needs Consult intelligenceBooked, run, and written up MURs and MTAsFor consultant pharmacists Dispensing & business Coming soonPOS, pickup, stock, and the books Patient app Coming soonScripts, payments, documents

Fit & proof

IntegrationsStart without replacing anything Operator economicsThe numbers that move the P&L How we compareQiri vs traditional CDS Sources & methodologyWhere each figure comes from
Pricing About Pharmacist login
Book a demo

Legal

  • Privacy Policy
  • Software User Agreement
  • Patient Terms of Use
  • Delete your account

On this page

    Software User Agreement

    Last updated: 18 October 2026

    Please read this Agreement before using the Platform. It is a binding contract.

    This Software User Agreement (Agreement) is between you (User, you, or your) and JAVEDSHEIKH PTY LTD, a company registered in Australia (ABN 54 679 727 827), trading as Qiri (Qiri, we, us, or our). It governs your access to and use of the Qiri software platform (the Platform) and the services we provide with it (the Services).

    This Agreement governs use of the Platform by pharmacies, pharmacists, and pharmacy staff (Pharmacist Users), who use the Platform as a clinical decision support and pharmacy operations platform to assist their professional practice.

    This is the New Zealand version of the Agreement. It applies to a Pharmacy Account for its sites in New Zealand, and to Pharmacist Users when they work at those sites. Where a Pharmacy Account also has sites in Australia, the Australian version applies to those sites.

    Patients (Patient Users) who use the Platform directly, including through the Qiri patient app, do so under the separate Patient Terms of Use, not this Agreement. Where a patient interacts with a pharmacy through the Platform, the pharmacy's obligations in respect of that interaction are set out in this Agreement.

    You accept this Agreement as clause 1 describes. If you do not agree, do not use the Platform.

    Part A: Foundational Terms

    1. Acceptance of Terms

    By accepting this Agreement, you acknowledge that you have read, understood, and agree to be bound by this Agreement, including any additional terms, policies, or schedules referenced in it. If you are entering into this Agreement on behalf of a company, pharmacy, or other legal entity, you represent that you have authority to bind that entity.

    You accept this Agreement by selecting the acceptance box in the Platform, which is never selected for you, when you create an Account, when you accept an invitation to a Pharmacy Account, or when the Platform asks you to accept an updated version. Qiri records the version you accepted, when you accepted it, and how. You may not use the Platform until you have accepted this Agreement. We may update this Agreement from time to time. Where changes are material, we will provide reasonable prior notice (by email or in-product notification) and ask you to accept the updated Agreement in-product before you continue to use the Platform; your acceptance is recorded together with the version of the document you accepted. You agree that this Agreement may be entered into, and that notices under it may be given, by electronic means, as Part 4 of the Contract and Commercial Law Act 2017 allows. If you do not accept an update, you must stop using the Platform. If the update is a material change and you end this Agreement because of it, by notice given before the update takes effect for you, Qiri refunds the Fees you have prepaid for the period after the Agreement ends.

    Where you access the Platform under a separate written agreement signed by Qiri and by you or your pharmacy (a Separate Written Agreement), that agreement governs to the extent of any inconsistency with this Agreement. Unless a Separate Written Agreement says otherwise, this Agreement, including its Schedules, is the whole of the terms on which your pharmacy uses the Platform.

    2. Definitions and Interpretation

    2.1 Definitions

    In this Agreement, unless the context otherwise requires:

    • Account means a registered user account created to access or use the Platform.
    • AI Outputs means any data, text, content, recommendations, summaries, suggestions, or other material generated, produced, or output by the Platform, including through automated or artificial intelligence processes.
    • Beta Features means any features, functionality, services, tools, models, or releases that Qiri labels as beta, preview, early access, experimental, or similar in the product. A Beta Feature is available in the live Platform and may be used in the ordinary work of your pharmacy. It may be incomplete, may change, and may be modified, limited, suspended or withdrawn at any time. Clause 7 sets out the basis on which Beta Features are provided.
    • Confidential Information means any information that is not publicly available and that is disclosed in connection with the Platform, including technical information, business information, and User Content, but excludes information that is publicly available other than through a breach of this Agreement.
    • Consumer Guarantees Act means the Consumer Guarantees Act 1993.
    • Derived Data means data, statistics, insights, trends, and models generated or derived by the Platform from use of the Platform or processing of User Content, where that data is de-identified and aggregated such that it cannot reasonably be used to identify any individual or User.
    • Fair Trading Act means the Fair Trading Act 1986.
    • Feedback means any suggestions, comments, ideas, improvements, or other feedback provided by a User in relation to the Platform.
    • Free Plan means the no-charge Ask Qiri plan described in Schedule 2, and any other no-charge plan Qiri offers from time to time.
    • Health Information has the meaning given to health information in the HIPC, and includes information about an individual's health or medical history, any disability they have, the health or disability services provided to them, and information collected in the course of providing those services.
    • Health NZ Systems means the national digital health services operated by or for Health New Zealand | Te Whatu Ora (Health NZ), including the National Health Index (NHI), the Health Provider Index (HPI), the New Zealand ePrescription Service (NZePS) and the Medicines Data Repository.
    • HIPC means the Health Information Privacy Code 2020 issued under the Privacy Act.
    • HPCA Act means the Health Practitioners Competence Assurance Act 2003.
    • Intellectual Property Rights means all industrial and intellectual property rights throughout the world, whether registered or unregistered, including copyright, trade marks, patents, designs, circuit layouts, trade secrets, and rights to use and protect the confidentiality of information.
    • Qiri, we, us, or our means JAVEDSHEIKH PTY LTD, a company registered in Australia (ABN 54 679 727 827), trading as Qiri.
    • NHI number means the number assigned to an individual in the National Health Index.
    • NZ Formulary means the New Zealand Formulary and the medicines data published with it, as licensed to Qiri.
    • Patient Terms means the Qiri Patient Terms of Use available at www.qiri.ai/nz/patient-terms, as updated from time to time, which govern use of the Platform by Patient Users.
    • Patient User means a User who accesses the Platform as a patient, whether directly or through a Pharmacy Account.
    • Personal Information has the meaning given to personal information in the Privacy Act, and means information about an identifiable individual.
    • Pharmacist User means a User who accesses the Platform in their professional capacity as a pharmacist or pharmacy staff member, whether directly or through a Pharmacy Account.
    • Pharmacy Account means an Account created for or on behalf of a pharmacy or other healthcare organisation under this Agreement or a Separate Written Agreement, through which Pharmacist Users and (where applicable) Patient Users access the Platform.
    • Pharmacy Council means the Pharmacy Council of New Zealand, the authority responsible for pharmacists under the HPCA Act.
    • Platform means the Qiri software platform operated by us, including the pharmacist console, the Qiri patient app, Ask Qiri, and any associated applications, websites, interfaces, updates, upgrades, and documentation.
    • Privacy Act means the Privacy Act 2020.
    • Privacy Policy means Qiri's privacy policy available at www.qiri.ai/nz/privacy-policy, as updated from time to time.
    • Separate Written Agreement has the meaning given in clause 1.
    • Services means all services, features, functionality, interfaces, tools, and support provided by Qiri in connection with the Platform.
    • User , you, or your means any individual or entity that accesses or uses the Platform.
    • User Content means all data, content, files, prompts, instructions, and information (including any Personal Information or Health Information) that a User uploads to, inputs into, submits through, or otherwise makes available in connection with the Platform.
    • Website means any website operated by Qiri in connection with the Platform, including www.qiri.ai.

    2.2 Interpretation

    In this Agreement, unless the context otherwise requires:

    1. headings are for convenience only and do not affect interpretation;
    2. words in the singular include the plural and vice versa;
    3. a reference to a person includes an individual, partnership, corporation, or other legal entity;
    4. an amount in dollars, or written with $, is in New Zealand dollars unless the pricing schedule accepted for your Account says otherwise;
    5. a reference to legislation includes any amendment, re-enactment, or replacement of that legislation; and
    6. "including" means "including without limitation".

    3. About Qiri and Intended Use

    3.1 Patient Users and the Patient Terms

    Patient-facing functionality of the Platform (including the Qiri patient app) is provided to Patient Users under the Patient Terms, not this Agreement. References in this Agreement to Patient Users describe the pharmacy-side obligations that apply when patients interact with a Pharmacy Account. Pharmacist Users and Pharmacy Accounts access the Platform's clinical decision support and pharmacy operations functionality under this Agreement.

    3.2 Intended use

    The Platform is a software platform that uses artificial intelligence and rule-based safety checks to:

    1. assist Pharmacist Users with clinical decision support, including: screening of prescriptions before supply; responses to professional queries; summaries of relevant information; interpretation of pathology results and pharmacogenomic reports entered by the Pharmacist User; clinical calculators (including renal function estimates); counselling points; drafting of clinical notes and reports for the Pharmacist User to review; and safety alerts and summaries of regulator notices;
    2. support pharmacy operations as the pharmacy's dispensing and point-of-sale system of record where so deployed, including: prescription intake by scan, upload, manual entry and submission from the Qiri patient app; dispensing workflow, labelling and repeats; point of sale, till and end-of-day records; stock control; a controlled drugs register and movement record, as described in Schedule 5; accounting exports; patient records, including records imported from a previous system; and reporting on services delivered and on readiness to claim;
    3. support consultations and professional services delivered by the pharmacy, as described in Schedules 3 and 4; and
    4. provide Patient Users, through the Qiri patient app, with information about their prescriptions and services and general health information, as described in the Patient Terms.

    The Platform is not intended to be used for, and must not be used for:

    1. diagnosis of any medical condition. Interpretation of a result entered by a Pharmacist User is decision support for that Pharmacist User and is not a diagnosis;
    2. prescribing. Dispensing through the Platform is the act of the pharmacist who signs the dispensing decision, not of the Platform;
    3. emergency or urgent clinical decision making;
    4. replacing the professional judgement of a pharmacist, doctor, or other qualified health professional; or
    5. any purpose outside the scope described in this clause.

    Use of the Platform outside its intended use is at the User's own risk and may breach this Agreement.

    3.3 Planned integrations

    Qiri intends to connect the Platform with Health NZ Systems, including NZePS, the NHI, the HPI and the Medicines Data Repository, with the NZ Formulary, with Health NZ's claiming systems, and with third-party dispensing and accounting systems. A connection is available to your pharmacy only when Qiri has confirmed in writing (in the product or by email) that it is enabled for your Pharmacy Account. Until then you must not rely on the Platform for that function, and Qiri makes no representation that any planned connection will be delivered or when.

    3.4 Where the Platform is offered

    This version of the Agreement is offered to pharmacies in New Zealand and to pharmacists and pharmacy staff working at them. Qiri is an Australian company and provides the Platform from Australia, where it stores your pharmacy's records (clause 12.2(c)). Qiri's clinical sources are scoped to the country recorded for each of your sites, and outputs are not validated for any other country. Clinical content Qiri licenses for use in New Zealand, including the NZ Formulary, is available only at a site recorded as being in New Zealand, and you must not use it in clinical practice outside New Zealand. You are responsible for keeping the country recorded for each site correct, and for confirming that your use of the Platform is permitted by the laws and professional rules that apply to you.

    3.5 Changes to the Services

    Qiri improves the Services continually. Qiri may add to, improve and change the Services at any time, and changes will generally be improvements and additions rather than removals. Where Qiri intends to withdraw or materially reduce a capability your pharmacy relies on, or to make a change that requires you to change how you work, Qiri will give reasonable prior notice in the product or by email, and where practicable at least 30 days. Changes to Fees are governed by clause 11.3, and changes to this Agreement by clause 1.

    3.6 A tool, not compliance

    1. The Platform is a tool to help your pharmacy and its Users meet their legal and professional obligations. It does not meet them for you. Your pharmacy, the holder of its licence to operate a pharmacy, its Responsible Person, the pharmacist supervising it under section 42A of the Medicines Act 1981 and its other Users remain responsible, as the law that applies to each of them provides, for complying with every law, professional standard and condition of registration or licence that applies to the pharmacy and its practice, including the laws governing the supply, recording, storage and handover of medicines.
    2. Where the Platform prompts, warns, reminds, applies a setting, suggests or converts a value, or asks a User to confirm a step, it does so to assist. A prompt is not a statement of what the law requires, and the absence of a prompt or warning is not a statement that nothing is required. Whether a supply, a record or any other act is lawful is for your pharmacy and its pharmacists to decide.
    3. Where a User confirms a value or a step, or records what was done, that is the User's own statement. Qiri does not verify it.
    4. Subject to clauses 11.6, 17 and 19, Qiri is not liable for any loss, penalty, fine, enforcement action, licence condition or disciplinary outcome to the extent it arises from a failure by your pharmacy or its Users to comply with an obligation described in paragraph (a). This paragraph does not limit Qiri's liability for its own breach of this Agreement or its own negligence, which clause 19 governs.
    5. Your pharmacy's pharmacists keep their professional judgement, and your pharmacy keeps its operational and contracting decisions, including whether to use the Platform and how to set it up within what it offers. Nothing in this Agreement gives Qiri any right to direct a professional decision or to make an operational or contracting decision for your pharmacy. Qiri's rights to set the checks the Platform runs, to make features available or not, to remove content and to suspend access to protect patients, other users or the Platform (clauses 3.5, 12.3 and 16.1) concern the software Qiri supplies, and are not control of the practice of pharmacy.

    Part B: Access and Usage

    4. Licence

    Subject to this Agreement, Qiri grants you a limited, non-exclusive, non-transferable, revocable licence to access and use the Platform solely for your internal pharmacy or healthcare practice purposes, and strictly in accordance with this Agreement. Patient Users are licensed under the Patient Terms. No rights are granted except as expressly set out in this Agreement.

    5. Eligibility, Age Restrictions, and Paediatric Patients

    5.1 Minimum age for Account creation

    You must be at least 18 years old to create an Account. We may request verification of age at any time, and failure to provide verification may result in Account suspension.

    5.2 Information about minors

    Information about a person under 18 (a Minor) may be entered into the Platform only:

    1. by a Pharmacist User on a Pharmacy Account, in connection with the provision of pharmacy services to the Minor and with the consent of the Minor's parent, guardian, or other person with lawful authority; or
    2. by a parent, guardian, or other person with lawful authority who has created an account under the Patient Terms for that purpose.

    Any information about a Minor will be handled in accordance with the Privacy Policy and applicable privacy and health records laws.

    5.3 Removal of information collected without authority

    If we become aware that we have collected information about a Minor without appropriate authority, we will take steps to delete that information promptly. Parents, guardians, or persons with lawful authority may contact us at hello@qiri.ai to request deletion.

    6. Use of the Platform

    You must not, and must not attempt to:

    1. use the Platform in breach of any applicable law or regulation, including the Privacy Act, the HIPC, the Medicines Act 1981, the Misuse of Drugs Act 1975 and the regulations made under them;
    2. interfere with, disrupt, overburden, or damage Qiri or any systems or networks connected to it;
    3. access or use the Platform using automated means (including bots, scrapers, spiders, or similar tools) except where expressly permitted by Qiri in writing;
    4. reverse engineer, decompile, disassemble, or otherwise attempt to derive the source code of any part of the Platform, except to the extent permitted by law;
    5. modify, copy, adapt, translate, or create derivative works of the Platform except as expressly permitted by this Agreement;
    6. use the Platform to infringe any person's rights or to upload or distribute unlawful content;
    7. input Personal Information or Health Information about another person without lawful authority and (where required) the consent of that person or their authorised representative;
    8. use the Platform to attempt to obtain, supply, or self-administer medicines or controlled substances unlawfully;
    9. hold yourself out as a qualified health professional if you are not, or provide clinical advice to others through the Platform outside your scope of practice; or
    10. attempt to circumvent any clinical safety guardrails, content filters, or rate limits applied to the Platform.

    7. Beta Features

    From time to time, Qiri may make Beta Features available. A capability is a Beta Feature when Qiri labels it as beta, preview or early access in the product. Beta Features are provided "as is" and may be changed, suspended, or withdrawn at any time. To the maximum extent permitted by law, Qiri gives no warranties in relation to Beta Features.

    Pharmacist Users acknowledge that Beta Features must not be used as the sole or determining basis for any clinical decision, and that the Pharmacist User retains full clinical responsibility for any decision they make. Patient Users should not rely on Beta Features in connection with any health decision.

    If you provide feedback about Beta Features, you grant Qiri a perpetual, irrevocable, worldwide, royalty-free right to use that feedback without restriction or compensation. Qiri may require you to keep information about Beta Features confidential where notified to you in writing or within the Platform.

    Part C: Users and Accounts

    8. Patient Users

    Patient Users access the Platform under the Patient Terms. Where patients interact with your Pharmacy Account through the Platform (including by submitting prescriptions, nominating carers, booking consultations, receiving documents, or making payments):

    1. the pharmacy remains responsible for the health services and products it provides to the patient;
    2. the pharmacy must ensure patient information received through the Platform is handled in accordance with clause 10 and applicable privacy and health records laws; and
    3. any information provided to a patient through the Platform that is not provided to the patient, or authorised, by their pharmacist is general health information only. It does not take into account the patient's personal health profile and is not a substitute for the professional advice of a pharmacist, doctor, or other qualified health professional.

    9. Pharmacist Users and Professional Obligations

    If you are a Pharmacist User, you represent and warrant that:

    1. you are registered with the Pharmacy Council as a pharmacist, hold a current annual practising certificate, and work within your scope of practice and any conditions on it, or you are otherwise lawfully entitled to work as an intern pharmacist, pharmacy technician or other pharmacy staff member in New Zealand, under any supervision the law requires; and you will notify Qiri (or the pharmacy operating the relevant Pharmacy Account) promptly if your registration or practising certificate lapses, is suspended, is cancelled, or becomes subject to a condition that affects what you do on the Platform;
    2. you will use the Platform in accordance with the HPCA Act, the Pharmacy Council's Code of Ethics and competence standards, the Code of Health and Disability Services Consumers' Rights, and any other professional or regulatory obligations that apply to you;
    3. you will treat Platform outputs as decision support only, apply your own professional judgement to any clinical decision, and retain full professional responsibility for the decisions you make;
    4. you will maintain patient confidentiality and only enter Patient Personal Information or Health Information into the Platform as permitted by your pharmacy's Pharmacy Account configuration, with appropriate consent, and in accordance with applicable law;
    5. you will not use the Platform to provide clinical care outside your scope of practice or registration;
    6. where you use the Platform to contact a Patient User on any messaging channel Qiri makes available (for example email, in-app notification, SMS or a messaging app), you will obtain the patient's consent to be contacted on that channel before doing so, and you will not send Health Information through a channel unless the patient has consented to receive it that way; and
    7. you will not share your Account credentials with any other person;
    8. you will choose a strong password that meets any requirements the Platform states, will not use a password you use for another service, and will keep it confidential;
    9. where you set a signing PIN, you will choose one that is not easily guessed, will keep it to yourself, and will not allow any other person to sign, dispense or approve anything under it. An action taken with your signing PIN is recorded as yours;
    10. you will tell your pharmacy, and Qiri, as soon as you believe your Account credentials or your signing PIN have been used by someone else or are known to someone else; and
    11. where you use the Platform on a device other people can reach, including a dispensary or counter terminal, you will lock the screen or sign out before you leave it.

    10. Pharmacy and Enterprise Accounts

    Where the Platform is accessed through a Pharmacy Account:

    1. the pharmacy or organisation operating the Pharmacy Account controls patient Personal Information entered into the Platform through that Pharmacy Account, and Personal Information about any other person the pharmacy records in connection with a patient's care or a supply, such as a carer, a person collecting a medicine or a witness, and Qiri handles that information on the pharmacy's instructions in accordance with this Agreement and any Separate Written Agreement. The pharmacy is the agency responsible for that information under the Privacy Act and the HIPC. Qiri holds it for the pharmacy, as its agent within section 11 of the Privacy Act, and uses and discloses it only to provide the Platform to the pharmacy, except as clauses 12.2(d) and 12.2(e) and the Privacy Policy describe;
    2. Pharmacist Users accessing the Platform through that Pharmacy Account are bound by this Agreement, and Patient Users by the Patient Terms, and each by any policies, procedures, or instructions set by the pharmacy in relation to use of the Pharmacy Account;
    3. the pharmacy is responsible for instructing Qiri on retention, deletion, export, and access requests in respect of patient data, including for the purpose of meeting the pharmacy's record-keeping obligations under applicable law; and
    4. requests by patients to access, correct, or delete their Personal Information should generally be directed to the relevant pharmacy in the first instance. Qiri will assist the pharmacy in responding where required; and
    5. where the Pharmacy Account uses the Platform's patient messaging features, the pharmacy is responsible for obtaining each patient's consent to be contacted on the relevant channel. Messages sent on channels operated by third-party carriers leave Qiri's environment and may be processed or stored outside New Zealand and Australia by that carrier; the carriers in use are listed in the Privacy Policy. Qiri acts as a conduit for those messages and is not responsible for the content the pharmacy or its Pharmacist Users choose to send.
    6. Operator credentials. Where a site uses operator PINs, enrolment codes or other credentials that are not tied to a named Account, the pharmacy is responsible for issuing, securing and promptly revoking them, and for all activity conducted under them as if it were the pharmacy's own.
    7. Records Qiri originates. Qiri creates or updates patient records from prescription scans, from records imported from a previous system at the pharmacy's request, from record merges a Pharmacist User approves, and from what a Pharmacist User records a patient as taking. Each such record is created on the pharmacy's instruction. The pharmacy warrants that it has authority to bring imported records into the Platform, and the Pharmacist User who accepts a scan, an import mapping, a merge or a medicines entry is responsible for verifying it against the source.
    8. Identity information. The pharmacy may collect NHI numbers and, where the patient provides them, identity document details through the Platform and the Qiri patient app, only for identity confirmation, dispensing and claiming purposes, in accordance with rule 13 of the HIPC, Health NZ's conditions of access and the Privacy Policy.
    9. Booking embed. Where the pharmacy places the Platform's booking form on its own website, the pharmacy is responsible for that website, for telling patients that the form is provided by Qiri, and for keeping the list of permitted domains in its Platform settings current.
    10. Audit records. Qiri keeps an audit record of clinical decisions, consents, administrative actions and record changes on the Pharmacy Account, and provides the pharmacy with an export of that record on request for regulatory, audit and insurance purposes.
    11. Funder audit and subcontracting. Where your pharmacy's agreement with Health NZ (including the Integrated Community Pharmacy Services Agreement) gives Health NZ or its auditors access to records held for your pharmacy, including records held by its contractors or agents, Qiri will give that access to the records it holds for your pharmacy, through your pharmacy or directly, as that agreement requires. If Health NZ treats Qiri as a subcontractor of the services your pharmacy provides under that agreement, then, for so long as it does: your pharmacy is responsible for seeking Health NZ's approval, and Qiri will give your pharmacy the information it reasonably needs to seek it; Qiri will give Health NZ the direct access to its premises, records and personnel, and the audit rights, that the agreement requires of a subcontractor; Qiri will not subcontract those services further without the consent the agreement requires; Qiri will hold the insurance the agreement requires of a subcontractor; and Health NZ may enforce this paragraph against Qiri under subpart 1 of Part 2 of the Contract and Commercial Law Act 2017.

    Where the pharmacy uses the Platform as its dispensing system of record, Qiri hosts the pharmacy's dispensing, consultation, services and point-of-sale records to support the pharmacy's record-keeping obligations under applicable law. The pharmacy may export those records at any time during the term, using the export functions in the Platform for each record type and, for a complete export of the account, by written request to Qiri, and on termination in accordance with clause 16.1. Where the law requires a record to be kept at the pharmacy's premises or at another place an authority approves, your pharmacy is responsible for obtaining any approval needed for the Platform to hold it, and for being able to produce it at the premises when an authorised person asks.

    For all other Personal Information collected through the Platform (including direct Pharmacist User accounts not associated with a Pharmacy Account, account contact details, and billing information), JAVEDSHEIKH PTY LTD is the controller.

    Part D: Fees and Commercial Terms

    11. Fees and Payment

    11.1 Service plans

    Qiri may be offered under different service plans, including free (Free Tier) and paid subscriptions (Paid Services). If you elect to use Paid Services, you agree to pay the fees specified in the pricing schedule accepted through your Account, on the Website, or at checkout (Fees). Pharmacy Account pricing is set in the pricing schedule accepted in-product by the pharmacy's authorised administrator, or in a Separate Written Agreement, and does not take effect until so accepted.

    Qiri provides support for the Services in accordance with Schedule 1 (Support). The support plan applying to a Pharmacy Account is determined by its accepted pricing schedule or a Separate Written Agreement; where none is specified, Standard Support applies. Ask Qiri Standalone plans receive support as described in Schedule 2 (Ask Qiri Standalone), and Consult plans as described in Schedule 6 (Consult plan).

    11.2 Billing and auto-renewal

    1. Billing cycle. Fees are billed in advance on a monthly or annual basis, depending on your selection.
    2. Auto-renewal. Your subscription will automatically renew at the end of each billing cycle unless you cancel through your Account settings before the renewal date.
    3. Payment method. You authorise Qiri to charge your designated payment method for all Fees. You are responsible for keeping your payment information current.

    11.3 Changes to Fees

    1. Reviews. This clause applies to Pharmacy Accounts. In it, Fees include the platform fee under clause 11.7, and for the 12-month limit below the Fees for your Paid Services are one Fee and the platform fee is another. Qiri may change its Fees, including by introducing a new charge for something your pharmacy already uses, after a review of its pricing. An increase to a Fee may not take effect within 12 months of the previous increase to that Fee taking effect. Where one review increases both, Qiri will tell you about both in one notice.
    2. What counts as an increase. A change is an increase if any Fee, or any component of a Fee, rises for any period or any transaction. The end of a promotional price, free period or discount on the terms stated when it was offered under clause 11.8 is not an increase.
    3. Notice. Qiri will give your pharmacy's administrators at least 30 days' written notice under clause 30 of any increase. The notice will state the current and new Fees, the date each increase takes effect, and how and by when you may exercise your options under paragraph (e).
    4. When an increase takes effect. An increase to the Fees for your Paid Services takes effect at the start of the first billing period that begins after the notice period ends or, if your pharmacy has no current billing period, on the date stated in the notice. An increase to the platform fee takes effect on the date stated in the notice, which is after the notice period ends. Fees you have already paid for a billing period are never increased, and if Qiri charges an increase before it may take effect, it will refund the difference.
    5. Your options. You do not need to accept an increase. At any time before it takes effect you may: (i) cancel the affected Paid Services, in your Account settings or by notice to Qiri. No cancellation fee applies and you pay nothing at the increased Fees. Full service continues to the end of your current billing period, and the wind-down under clause 11.4 runs from then; or (ii) for an increase to the platform fee, stop using Patient Payments, or turn off the way of taking payment the increase applies to, in your Platform settings, and keep using the rest of the Platform.
    6. Additions you ask for. Fees for sites, users, services or ways of taking payment your pharmacy adds at its request are agreed when it adds them, in an updated pricing schedule accepted under clause 11.1 or at the rate shown in your Platform settings when you turn it on. They may be charged from that date, are not an increase, and do not change the Fees for anything your pharmacy already has.
    7. Reductions. A change that is not an increase may take effect immediately.
    8. Separate Written Agreements. Where a Separate Written Agreement fixes Fees for a period, it prevails over this clause.
    9. Third-party charges. This clause applies only to Fees Qiri charges. It does not apply to the payment provider's own processing fees under clause 11.7(a), or to any other charge a third party makes to your pharmacy directly. Those are set by the third party, may change under your pharmacy's agreement with it, and are not limited by this clause.

    For Ask Qiri Standalone and other individual plans, Qiri may change Fees or introduce new charges. We will provide at least 30 days' prior notice (by email or in-product notification) of any price increase, and you may cancel the affected Paid Services before the change takes effect.

    11.4 Failure to pay, and cancellation

    1. Individual plans. If we are unable to charge the payment method on an Ask Qiri Standalone or other individual plan, or if you cancel it, your Account moves to the Free Plan at the end of the period you have paid for. Your history remains available on the terms of the Free Plan.
    2. Pharmacy Accounts. Warning. If a payment for a Pharmacy Account fails, we will tell the pharmacy's administrators in the product and by email, and Qiri continues to operate in full while the payment provider retries.
    3. Pharmacy Accounts. Wind-down. If payment has not been made when those retries are exhausted, or if the pharmacy cancels its subscription, Qiri will notify the pharmacy's administrators in writing and a wind-down period of 60 days runs from that notice. During wind-down Qiri does not suspend the pharmacy's access to its records. The pharmacy and its Pharmacist Users may sign in, read every record and export every record at no charge, and may request a complete export from Qiri, but Qiri may close new prescription intake, new bookings, new payments and new electronic submissions, and may tell patients using the Qiri patient app that the pharmacy is not currently accepting submissions. Restoring payment before the wind-down ends restores full service.
    4. After wind-down. When the wind-down period ends, Qiri may suspend the pharmacy's access other than for the purpose of exporting its records. Retention, hand-back and deletion of the pharmacy's records are then governed by clause 16.1.
    5. We will not suspend or wind down a Pharmacy Account while a credit or refund we owe the pharmacy is unresolved, while a billing dispute the pharmacy has raised with us in writing is open, or while a support escalation the pharmacy has raised is unresolved. Nothing in this clause limits a right you have at law that cannot be excluded.
    6. This clause is the notice that applies to suspension for non-payment or cancellation. The notice in clause 16.1(b) applies to termination or suspension for other reasons.

    11.5 Taxes

    Unless expressly stated otherwise, amounts payable under this Agreement are exclusive of goods and services tax (GST). Qiri is not resident in New Zealand and supplies the Platform and the Services to your pharmacy as remote services. Where your pharmacy has told Qiri that it is registered for GST and has given Qiri its GST number or its New Zealand Business Number, Qiri treats the supply as made outside New Zealand and does not charge New Zealand GST, and your pharmacy accounts for any GST the Goods and Services Tax Act 1985 requires it to account for on the supply. If Qiri is required to charge GST on a supply under this Agreement, your pharmacy must pay an amount equal to that GST in addition, at the same time as the amount for the supply, and Qiri will give your pharmacy the taxable supply information that Act requires. Terms used in this clause have the meaning given in the Goods and Services Tax Act 1985. Tax on amounts your pharmacy charges its patients is dealt with in clause 11.7(d).

    11.6 Refunds, and New Zealand consumer law

    Fees paid for Paid Services are generally non-refundable, except as this Agreement provides. You and Qiri agree that:

    1. your pharmacy acquires the Platform and the Services for the purposes of a business, and you and Qiri are each in trade;
    2. the Platform and the Services are not of a kind ordinarily acquired for personal, domestic or household use, so your pharmacy does not acquire them as a consumer within the meaning of the Consumer Guarantees Act; and, as section 5D of the Fair Trading Act permits, sections 9, 12A, 13 and 14(1) of the Fair Trading Act do not apply to anything Qiri supplies under this Agreement, and it is fair and reasonable that you and Qiri are bound by this paragraph. You have had the opportunity to obtain legal advice before accepting this Agreement; and
    3. where a guarantee, right or remedy applies that cannot be excluded, nothing in this Agreement excludes it, and clause 19.3 applies to it.

    11.7 Patient payment processing and platform fees

    Where Qiri enables a Pharmacy Account to take payments from patients, whether for prescription medicines, other goods, consultations or other services, and whether in the pharmacy, through the Qiri patient app or by a payment link (Patient Payments), the following applies:

    1. Payment processing. Patient Payments are processed by our third-party payment provider (named in the Privacy Policy) through a payment account in your pharmacy's own name. To take Patient Payments your pharmacy must open that account and accept the provider's terms directly with the provider, and must keep meeting them. Qiri is not a party to that agreement and cannot accept it for you. Whether to open that account, and whether to keep it open, is the provider's decision, and Qiri does not promise that your pharmacy will be approved. If the provider declines to open the account, or later suspends or closes it, your pharmacy cannot take Patient Payments by card through the Platform while that continues, the rest of the Services remain available to your pharmacy, and no platform fee is payable. The provider's decision does not change the Fees for the rest of the Services and does not entitle your pharmacy to a refund. Your pharmacy may cancel under clause 11.4, as it may at any time, and clause 11.6 applies to Fees already paid. Your pharmacy is the merchant of record for every Patient Payment. Patient Payments are paid into your pharmacy's payment account, not to Qiri, and Qiri receives only its platform fee under clause 11.7(b). The provider charges your pharmacy its own payment processing fees and deducts them from that account. Your pharmacy is responsible, in accordance with the provider's terms, for refunds, chargebacks and disputes, and the provider may debit the amount of a chargeback, and any fee it charges for one, from that account. If the provider recovers any of those amounts from Qiri rather than from your pharmacy's payment account, your pharmacy must reimburse Qiri that amount on request. Patient Payments are presented inside the Platform for the convenience of your pharmacy and its patients, and that does not change who is responsible. Qiri does not hold your patients' money, does not decide a dispute, and does not become the merchant, the refunder or the party liable for a chargeback because the payment was taken on a Qiri screen. Your pharmacy has its own access to the provider's dashboard for the payments it takes, and responds to a dispute there. Qiri will pass on the transaction records it holds to help your pharmacy answer one, and is not responsible for the outcome. Your agreement with the provider governs the payment account, the provider's fees and the handling of refunds, chargebacks and disputes, and prevails over this clause to the extent of any inconsistency about those matters.
    2. Qiri platform fee. Qiri charges a platform fee on each Patient Payment taken by card through the Platform, to cover the cost of providing the payment facility and the technology behind it. The fee may be a fixed amount per transaction, a percentage of the amount of the transaction, or both. The platform fee is charged by Qiri and is in addition to the payment provider's own processing fees under clause 11.7(a). It is not a share of those fees, and paying one does not reduce the other. Amounts paid out to your pharmacy are net of both. The fee may differ according to how the payment is taken, that is, whether it is taken in the pharmacy, in the Qiri patient app, by a payment link, or when a consultation is booked, and according to the type of card used. It may have a minimum or a maximum amount per transaction, may vary with the amount of the transaction or with the value of Patient Payments your pharmacy takes over a period, and may differ between pharmacies. It does not differ according to what the transaction is for. The fee that applies to your pharmacy is stated in your pricing schedule and in your Platform settings, and the amount charged is shown on each transaction record. It is deducted at the time of the transaction. The platform fee is Qiri's revenue and is payable by your pharmacy out of the amount it receives for the sale. It does not change the price your patient pays, and Qiri never adds a surcharge to a patient. It is not a charge on the pharmacy's goods or services, and it is not a charge on, or a deduction from, any subsidy or other payment Health NZ or another funder makes to your pharmacy. Where the fee is a percentage, it is calculated on the amount of the Patient Payment, being the amount your patient pays your pharmacy. Where a Patient Payment is refunded in full or in part, Qiri returns its platform fee in the same proportion. A chargeback is not a refund for that purpose, and the platform fee on a Patient Payment that is charged back is not returned. Cash and other non-card tenders recorded in the Platform carry no platform fee.
    3. Changes. The platform fee changes only in accordance with clause 11.3. A reduction may take effect immediately. An increase takes effect on the date stated in the notice, which may differ from the date an increase to your other Fees takes effect. Before an increase takes effect you may stop using Patient Payments, or turn off the way of taking payment the increase applies to, in your Platform settings, and your pharmacy may keep using the others, or you may cancel under clause 11.3(e)(i).
    4. GST. Each line of a Patient Payment carries the GST treatment your pharmacy sets for it in the Platform. Qiri applies the default settings shown in your Platform settings and reports GST on that basis, at the New Zealand rate, in your till and accounting exports. Those defaults are settings, not a determination of, or advice about, the GST treatment of any supply your pharmacy makes. Your pharmacy is responsible for determining whether each supply it makes is a taxable supply, zero-rated or exempt under the Goods and Services Tax Act 1985, for setting each line correctly, for issuing any taxable supply information that Act requires, for checking the Platform's records and reports before relying on them, and for its own tax obligations in respect of Patient Payments it collects. Qiri does not provide tax, accounting or legal advice, and nothing in the Platform, its settings or its reports is such advice.
    5. Refunds, discounts and disputes. Refunds, partial refunds and discounts are decisions of the pharmacy, recorded against the operator or Pharmacist User who made them. The pharmacy is responsible to the patient for them. Responsibility to the payment provider for a chargeback or dispute is dealt with in clause 11.7(a).

    11.8 Promotions, referrals and trials

    Qiri may offer free periods, onboarding periods, promotional prices, referral rewards and retention offers. Each is provided on the terms stated when it is offered and recorded on your Account. Unless those terms say otherwise: an offer is personal to the Account it is made to and cannot be transferred; a free or onboarding period is granted once and does not restart on a change of plan or price; Qiri may withdraw or change an offer for the future on notice, without affecting a benefit already applied to your Account; a referral reward is a credit or discount only and creates no agency, partnership or entitlement to commission; and Qiri may decline or reverse a reward obtained by creating Accounts that are not genuine.

    Part E: User Content, Intellectual Property, and Privacy

    12. User Content and Licence

    12.1 User responsibility

    You are solely responsible for all User Content you upload, post, or otherwise transmit via the Platform. You represent and warrant that:

    1. you are the owner of all User Content, or you have all necessary rights, licences, consents, and releases to grant Qiri the rights in this Agreement;
    2. the User Content does not infringe, misappropriate, or violate any third party's Intellectual Property Rights, rights of publicity, or rights of privacy; and
    3. where you connect a third-party account or system (for example an accounting system or an identity provider) to Qiri, or place the Platform's booking form on your own website, you have confirmed that the third party's terms permit the connection and the use of data through the Platform.

    12.2 Licence to Qiri

    1. Operating licence. You grant Qiri a worldwide, non-exclusive, royalty-free, transferable, and sublicensable licence to use, reproduce, modify, adapt, publish, and display your User Content solely as necessary to provide, maintain, and support the Platform during the term of this Agreement.
    2. AI improvement use. You grant Qiri a worldwide, non-exclusive, royalty-free licence to use de-identified and aggregated User Content and usage data to train, tune, validate, and improve Qiri's own proprietary models and Services. Consistent with the Privacy Policy, we do not use patient health information, clinical prompts, medication histories, or consultation records, in any form, to train, fine-tune, or improve any public or shared third-party foundational AI model, and we do not use User Content that identifies you to train public models. Any third-party AI provider we engage is one whose published terms do not permit it to use your prompts or outputs for its own model development or other secondary purposes.
    3. Where processing happens. Qiri stores all patient records, prescription images, consultation recordings and transcripts in Australia, including those of pharmacies in New Zealand, and performs prescription scanning, speech-to-text, translation and de-identification in Australia. The records of pharmacies in New Zealand are held in a clinical database, file storage and services kept for New Zealand alone (the New Zealand environment), in Google Cloud's Sydney region, encrypted under a key used only for New Zealand, and separate from the records of Australian pharmacies. The directory of Users, Accounts and sites, which holds no patient records, is shared with Australia so that a User can sign in. Health NZ Systems and the NZ Formulary serve only the New Zealand environment. Qiri does not send a prescription, or any other information about a patient, from a site in New Zealand outside Australia. Qiri's reasoning platform, parts of which operate outside Australia and New Zealand, therefore does not receive it. The Platform's clinical reasoning features (the checks that screen a prescription with Qiri's reasoning, Ask Qiri, the interpretation of results, the drafting of notes and reports, and consult intelligence) are available at a site in New Zealand only once Qiri has confirmed in writing (in the product or by email) that the reasoning they need runs in Australia, and clause 3.3 applies to them until then. The full list of the providers and countries involved is in the Privacy Policy and Qiri keeps it current. We handle Personal Information in accordance with the Privacy Policy.
    4. Pharmacy Account data. The AI improvement licence in the "AI improvement use" paragraph above does not apply to User Content entered through a Pharmacy Account in respect of patients of that pharmacy, and Qiri does not use that User Content to train models, for research, or for any other secondary purpose. Qiri does use de-identified decision records from Pharmacy Accounts (the prescription, the checks that ran, the pharmacist's decision and the outcome, with identifiers removed in Australia; those from sites in New Zealand stay in Australia, as clause 12.2(c) describes) to operate, evaluate and improve the safety checks and reasoning that every pharmacy on the Platform relies on, and the pharmacy's Pharmacist Users see the result of that in the reasoning shown with each decision.
    5. Derived Data. Qiri may create Derived Data from use of the Platform. Qiri owns all right, title, and interest in Derived Data. You acknowledge that, due to the nature of machine learning, Derived Data cannot be reversed, removed, or "unlearned" once incorporated into a model, even after termination of this Agreement or deletion of your Account. Qiri handles Derived Data in accordance with the safeguards described in the Privacy Policy, including its commitment not to publicly release de-identified clinical histories. For Pharmacy Account data, Derived Data is created only from de-identified records, as described in the Privacy Policy.

    12.3 Prohibited content

    You must not upload, generate, or share content that is defamatory, obscene, pornographic, incites violence, infringes Intellectual Property Rights, or otherwise violates any law (Prohibited Content). You must also not upload or generate:

    1. Personal Information or Health Information about another person without lawful authority;
    2. content intended to obtain, supply, or self-administer medicines or controlled substances unlawfully; or
    3. content intended to circumvent the Platform's clinical safety guardrails or content filters.

    Qiri may remove Prohibited Content or suspend or terminate Accounts where reasonably necessary to protect users, comply with law, or enforce this Agreement. Where practicable, Qiri will provide notice and an opportunity to appeal, except where doing so would create risk, be unlawful, or compromise safety or investigations.

    13. Intellectual Property

    All content, features, and functionality (including software, text, displays, images, video, and audio) on or in the Platform are owned by Qiri, its licensors, or other providers of such material and are protected by New Zealand, Australian and international copyright, trade mark, patent, trade secret, and other intellectual property and proprietary rights laws.

    14. Health NZ Systems, the NHI and the NZ Formulary

    Connection to Health NZ Systems and to the NZ Formulary is planned and is governed by clause 3.3. Once a connection is enabled for your Pharmacy Account:

    1. access to a Health NZ System is granted by Health NZ. To your pharmacy, under the agreement your pharmacy makes with Health NZ as a health provider, and to Qiri, under its own agreement as your pharmacy's IT supplier. Your pharmacy must make and keep its agreement, and its use of a Health NZ System through the Platform must comply with that agreement, with Health NZ's conditions of access and with the HIPC, including rule 13 on the NHI number;
    2. only Users your pharmacy has authorised, acting in their professional capacity, may use a Health NZ System through the Platform. Every request Qiri sends to a Health NZ System identifies the User who makes it, as Health NZ requires, so a User must never allow another person to act under their Account;
    3. a Health NZ System is used only for the purpose Health NZ permits for it. NZePS is used only to dispense electronic prescriptions, and the Medicines Data Repository only by a pharmacist caring for the patient, for that care;
    4. Qiri may suspend access, logs every request it sends to a Health NZ System, and may report misuse to Health NZ or another authority where the law or its agreement with Health NZ requires;
    5. Qiri stores information from Health NZ Systems in Australia, in the New Zealand environment with the rest of your pharmacy's records, as clause 12.2(c) describes, and does not send it outside Australia;
    6. content from the NZ Formulary is licensed to Qiri for use in clinical practice in New Zealand only. It is available only at a site recorded as being in New Zealand; your pharmacy must not use it in clinical practice outside New Zealand, or copy, extract or redistribute it except as the Platform allows; and Schedule 8 applies to it; and
    7. Qiri uses information from Health NZ Systems and the NZ Formulary only to provide the Platform to your pharmacy for the care of the patient the information is about, and for no other purpose. Qiri does not use that information to train or improve any artificial intelligence model, for Ask Qiri, for analytics or for marketing, and does not disclose it except as this Agreement or the law requires.

    15. Privacy and Data Protection

    We collect, use, and disclose Personal Information, including Health Information, in accordance with the Privacy Policy, which is incorporated into this Agreement by reference. Health Information is subject to the Privacy Act and the HIPC, and to the other laws the Privacy Policy describes.

    We implement reasonable technical and organisational measures to protect User data against unauthorised access, loss, or misuse, as Schedule 7 sets out. Where a privacy breach affects Personal Information Qiri holds for your pharmacy, Qiri will tell your pharmacy without undue delay, and in any case within 24 hours of becoming aware of it, give it the information it needs to assess whether the breach is a notifiable privacy breach under Part 6 of the Privacy Act and to notify the Privacy Commissioner and the people affected, and help it to do so. Your pharmacy decides whether and how to notify, and Qiri will not notify in your pharmacy's name without its agreement unless the law requires it. Where a breach affects Personal Information Qiri holds for itself, Qiri notifies as the Privacy Act requires.

    Qiri holds Personal Information for your pharmacy outside New Zealand, in Australia, and some of it is processed in the other countries the Privacy Policy lists. Qiri agrees to protect that information with safeguards comparable to those the Privacy Act and the HIPC require, including by complying with the Privacy Policy, and requires the same, by contract, of every provider that stores or processes it for Qiri. Qiri gives this commitment so that your pharmacy may rely on it under information privacy principle 12 and rule 12 of the HIPC if any transfer of that information to Qiri, or by Qiri, is a disclosure.

    The roles of Qiri and any pharmacy operating a Pharmacy Account in respect of patient Personal Information are set out in clause 10 and any Separate Written Agreement.

    Part F: Termination

    16. Termination

    16.1 Termination and suspension

    We may terminate this Agreement or suspend your access to the Platform: (a) immediately, where you materially breach this Agreement, where suspension is reasonably necessary to protect patients, other users, or the security or integrity of the Platform, or where required by law; or (b) for any other reason, on at least 30 days' prior written notice, or, for a Pharmacy Account, at least 90 days' prior written notice. Where Qiri terminates under paragraph (b), it refunds the Fees prepaid for the period after termination. Upon termination, your right to use the Platform will cease.

    On termination of an individual plan, except in cases involving Prohibited Content or breach of clause 12, Qiri will provide you with a reasonable opportunity (not less than 30 days) to download or export your User Content before deletion.

    For Pharmacy Accounts, whether termination follows non-payment, cancellation, closure or sale of the pharmacy, or termination by Qiri under paragraph (b):

    1. the pharmacy has the 60-day wind-down period described in clause 11.4(c) (which, where Qiri terminates under paragraph (b), begins when the notice period ends), or such longer period as Qiri agrees in writing, to export its records, and Qiri provides on written request during that period an export of the pharmacy's complete dispensing, consultation, services, point-of-sale, controlled drugs register and audit records in a documented format;
    2. the pharmacy remains responsible for retaining its records for the periods required by law (for example, health information for at least 10 years from the day after the last date on which the pharmacy provided services to the patient, under the Health (Retention of Health Information) Regulations 1996; paper prescriptions and the prescription records for at least 3 years, under regulations 42 and 58 of the Medicines Regulations 1984; the controlled drug register and prescription book for 4 years after the last entry, under regulation 42 of the Misuse of Drugs Regulations 1977; and any longer period its agreement with Health NZ requires, the longest period applying to each record), and the export is the means by which it does so, including on a transfer of its records to a replacement provider;
    3. after the wind-down period Qiri retains the pharmacy's records, and its own audit record of the account, for the period Qiri is itself required by law to keep them, which is the retention period in paragraph (ii) applied to each record. During that period Qiri holds the records securely, does not use them for any purpose other than meeting its own legal obligations, responding to a lawful request from a regulator, or providing them to the pharmacy or its lawful successor on written request, and provides that export at no charge on the first request and at a reasonable archive fee for further requests, except that where the Pharmacy Account ended after a wind-down that followed non-payment, Qiri may charge for any export it provides, including the first, a fee that recovers its cost of preparing the export, as stated on the Website. The fee does not depend on the pharmacy paying any amount it owes, and does not affect a patient's right to obtain their records from the pharmacy. At the end of the period Qiri deletes the records, per patient by reference to the date of last service and date of birth, and confirms deletion to the pharmacy's last known contact where practicable;
    4. where the pharmacy is sold, Qiri will on the written instruction of the pharmacy's owner provide the records to the acquiring pharmacy and record the transfer in the audit record; and
    5. patients linked to the pharmacy through the Qiri patient app are told that the pharmacy is no longer available in the app and are shown how to obtain their records from the pharmacy.

    Suspension or termination of an individual Pharmacist User's Account does not, of itself, delete patient User Content held within the relevant Pharmacy Account.

    16.2 Survival

    All provisions of this Agreement that by their nature should survive termination will survive termination, including clauses 12.2 (Licence to Qiri), 13 (Intellectual Property), 17 (Disclaimer of Warranties), 19 (Limitation of Liability), 20 (Indemnity), 21 (No Publisher Liability), 22 (Confidentiality), 27 (Dispute Resolution), and 28 (Governing Law and Jurisdiction).

    Part G: Warranties, Liability, and Risk Allocation

    17. Disclaimer of Warranties

    The Platform is provided "as is" and "as available", without warranties of any kind, either express or implied, including implied warranties as to acceptable quality and fitness for purpose (to the extent applicable). We do not warrant that the Platform will be uninterrupted, error-free, or free of viruses or other harmful components. Clause 11.6 applies, and nothing in this Agreement excludes, restricts, or modifies a guarantee, right or remedy that cannot be excluded by law.

    18. AI Disclaimer

    18.1 Accuracy

    Qiri uses artificial intelligence and machine learning to generate AI Outputs. AI Outputs may be inaccurate, incomplete, or "hallucinated". You must verify AI Outputs before relying on them.

    18.2 Pharmacist Users, decision support only

    Qiri provides decision support to Pharmacist Users. AI Outputs are not a substitute for the Pharmacist User's professional judgement, training, or scope of practice. The Pharmacist User retains full professional responsibility for any clinical decision they make, including decisions informed by the Platform.

    18.3 Patient Users, general information only

    For Patient Users, any information or AI Output that is not provided to the Patient User, or authorised, by their pharmacist is general health information only. It does not take into account the Patient User's personal health profile and is not personal medical, legal, or financial advice. Patient Users should consult their pharmacist, doctor, or other qualified health professional before acting on any AI Output.

    18.4 Human review for high-risk use

    You agree to ensure that a qualified human (in the case of clinical use, a registered health professional acting within their scope of practice) reviews any AI Output before it is used in a context where error could result in death, injury, or significant financial or legal loss.

    18.5 Calculators, results and pharmacogenomic guidance

    Where the Platform provides a clinical calculator, an interpretation of a pathology result, or pharmacogenomic guidance, the output is an estimate or reading derived from the values the Pharmacist User entered and the sources Qiri cites. It is not a diagnosis. The Pharmacist User must verify the entered values against the source report, must not substitute one measure for another (for example an estimated glomerular filtration rate for a creatinine clearance), and must not use a calculator for a population it states it is not validated for.

    18.6 Content shown to patients

    Labels, expanded directions, counselling points, translations, documents and reports that Qiri drafts are issued to a patient only when a Pharmacist User approves them. The Pharmacist User who approves them is their author for all purposes, and is responsible for checking a translation with the patient where the Pharmacist User cannot read the target language. Your pharmacy decides which documents it offers, and is responsible for ensuring that issuing each of them is within the scope of practice and any authority of the Pharmacist User who approves it. Where your pharmacy creates or edits a document template, the content of that template is your pharmacy's and Qiri does not review it. A document issued to a patient is made available to them in the Qiri patient app, and may also be printed or given to them by your pharmacy; any notification Qiri sends about a document carries no clinical content, and your pharmacy remains responsible for giving a patient a copy by another means where they ask for one or cannot use the app.

    18.7 Reports and claims

    Where a Pharmacist User uses the Platform to prepare a medication review, a report or other document that is retained as a clinical record or submitted in support of a claim to a government or funded program, the Pharmacist User is the author of that document, is responsible for verifying every finding they accept, and the pharmacy is responsible for the accuracy of anything it submits for claiming. Qiri makes no representation that any claim will be accepted or paid.

    18.8 Alerts and summaries

    Safety alerts, recall notices and summaries of regulator publications shown in the Platform are drawn from public sources and may be incomplete or delayed. They do not replace the pharmacy's own subscription to regulator notices.

    18.9 What the safety checks are

    The Platform screens each prescription against rule-based checks and against reasoning generated by artificial intelligence, shows the result and the reasoning to the Pharmacist User, and records both with the decision. The rule-based checks are not changed by the artificial intelligence. A check can only act on the information the Platform holds. A check cannot fire on a fact that was not entered, was entered wrongly, or was not available from the sources the Platform uses. For that reason a result of "no issues found" means that the checks the Platform ran found none, and the Pharmacist User's review under clause 18.2 remains the safety control on every supply.

    19. Limitation of Liability

    19.1 No liability for indirect damages

    Subject to clause 19.6, to the fullest extent permitted by law, Qiri, its affiliates, directors, officers, employees, agents, suppliers, and licensors are not liable for any indirect, incidental, special, consequential, or punitive damages, including loss of profits, use, goodwill, or other intangible losses, and loss of data other than the records Qiri hosts for a Pharmacy Account, resulting from:

    1. your use or inability to use the Platform;
    2. any unauthorised access to or use of our servers and any Personal Information stored on them;
    3. any interruption or cessation of transmission to or from the Platform;
    4. any bugs, viruses, trojan horses, or similar transmitted to or through the Platform by any third party; or
    5. any errors or omissions in any Content or any loss or damage arising from your use of any Content posted, emailed, transmitted, or otherwise made available via the Platform, whether based on warranty, contract, tort (including negligence), or any other legal theory, whether or not we have been informed of the possibility of such damages.

    19.2 Maximum liability

    Subject to clause 19.6, to the fullest extent permitted by law, the aggregate liability of Qiri to you for all claims arising out of or relating to Qiri or this Agreement, whether in contract, tort, or otherwise, will not exceed the greater of: (a) the total amount you have paid to us for Qiri in the twelve (12) months before the event giving rise to the liability; and (b) for a Pharmacy Account, NZ$10,000.

    A Separate Written Agreement may set a different limit, which prevails over this clause to the extent of any inconsistency.

    19.3 Guarantees that cannot be excluded

    Where the Consumer Guarantees Act, the Fair Trading Act or any other law implies a guarantee, condition or warranty into this Agreement, or gives a right or remedy, that cannot be excluded despite clause 11.6, our liability for a failure to comply with it is limited, to the extent the law allows, to one or more of the following at our option. Resupplying the Services, or paying the cost of having the Services resupplied. Nothing in this Agreement excludes, restricts or modifies a guarantee, right or remedy that cannot be excluded, restricted or modified by law.

    19.4 Force majeure

    We are not liable for any failure or delay in performance caused by events beyond our reasonable control, including natural disasters, pandemics, government actions, internet or infrastructure failures, or acts of third-party service providers.

    19.5 Insurance

    On request we will tell you what insurance cover we hold in connection with the Services. Your pharmacy must hold and maintain professional indemnity insurance appropriate to the services it provides through the Platform, and public liability insurance where it delivers services at a patient's home, and will give Qiri evidence of that cover on reasonable request.

    19.6 Privacy and security breaches

    This clause applies to a Qiri Security Breach, which means a privacy breach, within the meaning of section 112 of the Privacy Act, affecting Personal Information Qiri holds for your pharmacy, or a loss or corruption of the records Qiri hosts for your Pharmacy Account, to the extent it is caused by Qiri's breach of clause 15 or Schedule 7, or by the negligence or wilful misconduct of Qiri, its personnel or its subcontractors. Because Qiri holds that information as your pharmacy's agent, the Privacy Act treats a breach by Qiri as your pharmacy's own, and this clause allocates that risk to Qiri.

    1. Clause 19.1 does not exclude Qiri's liability for a Qiri Security Breach, except for your pharmacy's own loss of profits or goodwill, and clause 19.2 does not apply to it. Instead, Qiri's aggregate liability for all Qiri Security Breaches arising in any 12-month period, including under paragraph (b), is limited to the greater of three times the Fees your pharmacy paid in the 12 months before the breach and NZ$250,000.
    2. Qiri indemnifies your pharmacy against the following, to the extent they arise from a Qiri Security Breach: the reasonable costs of investigating it, of assessing whether it is a notifiable privacy breach, and of notifying the Privacy Commissioner, the people affected and Health NZ; damages, costs and other amounts awarded against your pharmacy by the Human Rights Review Tribunal or a court in proceedings under the Privacy Act, or paid in a settlement Qiri has agreed to in writing; and the reasonable cost of recreating records Qiri hosts for your Pharmacy Account from another source where Qiri cannot restore them under Schedule 7.
    3. The indemnity in paragraph (b) does not cover a fine or penalty to the extent the law does not allow it to be indemnified, and is reduced to the extent your pharmacy or its Users caused or contributed to the breach, including by sharing credentials or a signing PIN or by failing to revoke a credential under clause 10.
    4. To claim under paragraph (b), your pharmacy must tell Qiri promptly of any complaint, investigation or claim, let Qiri conduct its defence and any settlement, give Qiri the help it reasonably asks for at Qiri's cost, and take reasonable steps to reduce its loss. Qiri will not admit fault or settle on your pharmacy's behalf without your pharmacy's agreement, which your pharmacy will not unreasonably withhold, and your pharmacy may take part in any proceeding with its own adviser at its own cost.
    5. Where records Qiri hosts for your Pharmacy Account are lost or corrupted, Qiri's first obligation, whatever the cause, is to restore them from its backups under paragraph 7 of Schedule 7 at its own cost, and to tell your pharmacy what could not be restored.

    20. Indemnity

    You indemnify us, our related bodies corporate, licensors and service providers, and their respective officers, directors, employees and agents, against any claims, liabilities, damages, judgments, awards, losses, costs, expenses, or fees (including reasonable legal costs) arising out of or relating to:

    1. your breach of this Agreement;
    2. your use of the Platform, including any use of the booking embed or any other interface Qiri provides for use on your own website or systems, in violation of third-party terms;
    3. your User Content, including any claim that your User Content infringes the Intellectual Property Rights of a third party;
    4. for Pharmacist Users, any claim arising from your professional practice or any clinical decision you make based on the Platform outputs; and
    5. any breach by you of applicable health, privacy, or medicines laws.

    Your liability under this indemnity is reduced to the extent that the relevant claim or loss was caused or contributed to by the negligence, fraud, or wilful misconduct of Qiri.

    21. No Publisher Liability

    You acknowledge that Qiri is a technology service provider and is not the publisher or author of any User Content or AI Outputs. You are solely responsible for any content you publish or share using the Platform. To the extent permitted by law, Qiri is not responsible for User Content made available by Users.

    Part H: Third-Party Relationships

    22. Confidentiality

    Each party must keep the other's Confidential Information confidential, use it only for the purposes of this Agreement, and disclose it only to its personnel and advisers who need it and are bound to keep it confidential, or where the law or a regulator requires. This clause does not restrict us from handling patient information as this Agreement and the Privacy Policy allow, or you from disclosing your own patients' information as your professional obligations require. On termination each party must return or destroy the other's Confidential Information on request, except records it must keep by law or under clause 16.1. If you believe material available through the Platform infringes your copyright or another person's, tell us at hello@qiri.ai and we will act consistently with the Copyright Act 1994.

    23. Third Party Terms

    Qiri may interoperate with third-party services, including pharmacy dispensing systems, identity providers, payment providers, and government health systems. Qiri accepts no liability for any loss or damage arising from your use of third-party services. Your relationship with any third party is governed by the third party's own terms.

    Part I: General Provisions

    24. Assignment, novation and subcontracting

    You may not assign, novate or otherwise transfer this Agreement or any right under it without our written consent, which we will not unreasonably withhold where the transferee is the purchaser of your pharmacy. We may assign or novate this Agreement to a related company (as the Companies Act 1993 defines it) or to a purchaser of our business on written notice to you, provided the transferee assumes our obligations. We may subcontract the performance of the Services to the providers listed in the Privacy Policy, and we remain responsible to you for their performance.

    25. Use of your name

    We may name your pharmacy as a user of the Platform in our marketing, and use its logo for that purpose, unless you tell us in writing not to. We will not describe your clinical practice or quote you without your written approval.

    26. Severability

    If any provision of this Agreement is held to be invalid or unenforceable, that provision will be severed and the remaining provisions will remain in full force and effect.

    27. Dispute Resolution

    If a dispute arises, the parties must first provide written notice to the other and attempt to resolve the dispute through good faith negotiation for not less than 30 days. If the dispute is not resolved, either party may refer it to mediation in New Zealand, which may be held by video, before commencing proceedings, except for urgent interlocutory relief. Nothing in this clause prevents a User from complaining to the Privacy Commissioner, the Health and Disability Commissioner or the Commerce Commission.

    28. Governing Law and Jurisdiction

    This Agreement is governed by the laws of New Zealand. Each party submits to the non-exclusive jurisdiction of the courts of New Zealand.

    29. Contact

    For questions about this Agreement, contact us at hello@qiri.ai.

    JAVEDSHEIKH PTY LTD (ABN 54 679 727 827), trading as Qiri

    PO Box 344, Revesby North NSW 2212, Australia

    30. Notices

    A notice under this Agreement must be in writing. We may give you notice in the Platform, or by email to the address of your Pharmacy Account's administrators or of your Account. You may give us notice by email to hello@qiri.ai. A notice sent by email is taken to be received on the next Business Day after it is sent, unless the sender receives a delivery failure. Business Day means a day other than a Saturday, Sunday or a public holiday observed throughout New Zealand under the Holidays Act 2003 (a regional anniversary day is not one).

    31. General

    This Agreement, with the Privacy Policy, the Patient Terms, the pricing schedule accepted for your Account and any Separate Written Agreement, is the entire agreement between you and us about the Platform and replaces any earlier understanding. A variation of this Agreement is effective only if made under clause 1 or agreed in writing by both parties. A failure or delay in exercising a right is not a waiver of it, and a single or partial exercise does not prevent a further exercise. Nothing in this Agreement makes either party the partner, agent, employee or joint venturer of the other. Each party bears its own costs of entering into this Agreement. Nothing in this Agreement limits or excludes a party's liability for its own fraud.

    Schedule 1: Support

    1. Support plans. Pharmacy Accounts include Standard Support. Advanced Support is an optional add-on for the fees, and for the sites, set out in the accepted pricing schedule or a separate written agreement with Qiri. Where Advanced Support is not specified for a site, Standard Support applies to that site.

    2. Support channels. Support is provided via the in-product help centre and by email to support@qiri.ai. A Severity 1 incident should be reported by email with "URGENT" at the start of the subject line, or by the in-product report function where one is shown. Service status is published at status.qiri.ai. Where Qiri notifies a Pharmacy Account of an additional urgent contact channel in writing, that channel is also available for Severity 1 incidents.

    3. Hours. Standard support hours are 9:00am to 5:30pm Sydney time (AEST/AEDT), Monday to Friday, excluding New South Wales public holidays (Business Hours). New Zealand is generally two hours ahead of Sydney, so these are generally 11:00am to 7:30pm in New Zealand. Severity 1 incidents are supported 8:00am to 9:00pm Sydney time, Monday to Saturday under Standard Support, and 8:00am to 9:00pm Sydney time on every day of the year under Advanced Support (each, as applicable, the Critical Support Window).

    4. Severity levels and response targets. Qiri will use commercially reasonable efforts to acknowledge support requests from Pharmacy Accounts within the following targets:

    1. Severity 1 (the Services are unavailable, or dispensing workflow at the site is blocked, or a suspected clinical safety defect): acknowledged within 30 minutes under Standard Support, or within 15 minutes under Advanced Support, in each case within the Critical Support Window and with continuous effort thereafter until restoration or a workaround;
    2. Severity 2 (a material feature of the Services is failing or degraded, but dispensing can continue): acknowledged within 8 Business Hours under Standard Support, or within 4 Business Hours under Advanced Support; and
    3. Severity 3 (general questions, minor defects, administrative and billing queries). Response within 2 business days under Standard Support, or by the next business day under Advanced Support.

    5. Advanced Support inclusions. Advanced Support additionally includes a named escalation contact and a quarterly service review. Advanced Support may be added or removed with effect from the next billing period, recorded in an updated pricing schedule accepted in accordance with clause 11.1.

    6. Nature of targets. Response targets are acknowledgement commitments. Qiri does not warrant resolution within any particular time and does not offer service credits. Nothing in this Schedule limits remedies otherwise available at law, and nothing in this Schedule limits a right you have at law that cannot be excluded.

    7. Exclusions. Response targets do not apply to faults arising from: electronic prescription networks and other upstream infrastructure not operated by Qiri; the User’s internet connectivity, local network, or hardware; Health NZ Systems and Health NZ's claiming systems; third-party services, including payment networks; or use of the Platform outside its intended use (clause 3.2).

    8. Business continuity. Qiri does not prevent a pharmacy from dispensing by its standard manual procedures during any unavailability of the Services. Pharmacies remain responsible for maintaining a downtime procedure as required by pharmacy practice standards.

    9. Maintenance. Qiri may perform scheduled maintenance and will use reasonable efforts to schedule it outside the Critical Support Window with at least 48 hours’ notice on the status page. Emergency maintenance may be performed at shorter notice.

    Schedule 2: Ask Qiri Standalone

    1. The plan. Ask Qiri Standalone is a per-user Paid Service plan providing Pharmacist Users with access to Ask Qiri. It does not include dispensing workflow, is not a system of record for dispensing, and does not include Pharmacy Account features unless separately subscribed.

    2. Professional use. Ask Qiri Standalone is provided for use by registered pharmacists in their professional practice. Clauses 3.2 (Intended use), 9 (Pharmacist Users and Professional Obligations), and 18 (AI Disclaimer) apply in full. Outputs are decision support only, are not personal medical advice, and do not replace the professional judgement of the pharmacist, who retains full professional responsibility for any clinical decision.

    3. Support. Ask Qiri Standalone is provided on a self-service basis. Support is available through the in-product help centre and by email to support@qiri.ai on a reasonable-efforts basis; the response targets in Schedule 1 do not apply, no support response times are committed, and telephone support is not included. Advanced Support is not available on Ask Qiri Standalone. Service status is published at status.qiri.ai.

    4. Billing and cancellation. Fees, billing, and auto-renewal are as set out in clause 11. Qiri aims to respond to billing and account requests within 1 business day and to process cancellation requests within 2 business days of receipt, with cancellation taking effect in accordance with clause 11. These are service goals, not contractual commitments.

    5. The Free Plan. Qiri offers a no-charge Ask Qiri plan (the Free Plan) with a monthly limit on questions, a limited history and a limited number of saved answers, as stated on the Website and in the product. The Free Plan is provided on the same professional-use basis as Ask Qiri Standalone, may be changed or withdrawn by Qiri on notice, and carries no support commitment beyond the help centre and the status page. An Ask Qiri Standalone plan that is cancelled or that Qiri cannot charge moves to the Free Plan under clause 11.4(a).

    Schedule 3: Consultations

    1. Scope. Qiri supports consultations delivered by the pharmacy in person, by video, by telephone and at the patient's home. The pharmacy decides which modes it offers and remains responsible for the clinical service, for the pharmacist's scope of practice, and for the safety of its staff during home visits.

    2. Booking. Patients book through the Qiri patient app, through a booking link, or through the booking embed on the pharmacy's website. Bookings are subject to the availability and services the pharmacy configures. Where the pharmacy takes payment at booking, clause 11.7 applies.

    3. Recording and transcription. Qiri records a consultation only with the patient's consent, and how that consent is obtained depends on how the consultation is delivered. For a video consultation the patient consents in advance through the Qiri patient app. For a consultation delivered in person, at the patient's home or by telephone, the Pharmacist User obtains the patient's agreement before starting to record, using the words Qiri displays, and Qiri records that it was obtained. Recordings are transcribed to text in Australia. Your pharmacy is responsible for obtaining and recording the patient's consent in the form Qiri presents, for any further consent the law that applies to it requires before a conversation is recorded, and for stopping a recording when a patient withdraws consent.

    4. The record, and what is kept. The Pharmacist User's consultation note is the clinical record of the consultation. The transcript is kept with it as part of the patient's record, unless it is deleted at the patient's request as described below. How long they must be kept is your pharmacy's responsibility under clause 16.1(ii), and what Qiri does with them after this Agreement ends is governed by clause 16.1(iii). A recording, whether audio or video, is not the record. It is a working copy kept so that the Pharmacist User can review it and correct the transcript. Every recording is deleted automatically 120 days after the consultation, Qiri shows the deletion date against each recording, and the deletion cannot be reversed. A patient may withdraw consent to recording at any time. Withdrawal stops any further recording. If a patient withdraws consent after the consultation, the Pharmacist User deletes the recording and its transcript in Qiri when the patient asks. The deletion cannot be reversed, the consultation note stays as the clinical record, and Qiri keeps a record of what was deleted, when and by whom, but none of its content. Requests to correct or restrict a record are handled by your pharmacy under clause 10(d).

    5. Consult intelligence. Where the pharmacy has enabled it, Qiri produces a summary, a list of medicines discussed and safety flags from the de-identified transcript of a consultation, for the Pharmacist User's review. This is decision support under clause 18 and is not part of the clinical record until the Pharmacist User adopts it into their note.

    6. Live captions. Where enabled and shown in the product, Qiri displays live captions during a consultation as an aid only. Captions are not stored as the record of the consultation and may be inaccurate.

    7. The service is your pharmacy's. Qiri provides the software that supports a consultation. The consultation itself is a professional service your pharmacy and its Pharmacist Users provide, subject to clause 9. Your pharmacy is responsible for deciding whether a consultation may lawfully be delivered in the way it is delivered and in the places where the Pharmacist User and the patient are each located; for satisfying itself of the identity of a patient in a consultation that is not delivered in person; for obtaining the patient's consent to the service itself, which is separate from consent to recording under paragraph 3; for ensuring that a User who is supervised at law acts under the supervision that law requires; and for every clinical decision the consultation calls for, including whether to refer a patient, to decline to proceed, or to direct a patient to urgent care. Your pharmacy is a health care provider for the purposes of the Code of Health and Disability Services Consumers' Rights and is responsible for meeting it, including the patient's right to make an informed choice and give informed consent, and the right to complain. Qiri is not an emergency or after-hours service. Qiri does not monitor a consultation, does not intervene in one, and does not decide whether one should take place.

    Schedule 4: Professional services and claiming

    1. Services. Qiri supports the delivery and recording of professional services the pharmacy provides, such as Extended Pharmacy Services and the Long Term Conditions service under the Integrated Community Pharmacy Services Agreement, and other services funded or commissioned by Health NZ, where Qiri makes them available from time to time. The pharmacy is responsible for its eligibility to deliver each service, including any agreement with Health NZ it needs, for the pharmacist's accreditation where required, and for delivering the service in accordance with that agreement and the service's rules.

    2. Claiming. Qiri records what the pharmacy has delivered and reports on its readiness to claim. Where Qiri lodges a claim on the pharmacy's behalf to a government or program administrator, it does so as the pharmacy's agent, on the pharmacy's instruction, using the credentials the pharmacy provides, and only for programs for which Qiri has confirmed in writing that lodgement is enabled for your Pharmacy Account. The pharmacy is responsible for the accuracy and clinical substantiation of every claim, for maintaining its own program registrations, approvals, certificates and credentials, and for any consequence of a claim being rejected, duplicated or audited. Qiri makes no representation that a claim will be accepted or paid. Until Qiri confirms in writing that lodgement with Health NZ, or with a regional claims portal, is enabled, Qiri does not lodge a claim for your pharmacy, and any claim summary Qiri prepares is for your pharmacy to check and lodge itself.

    3. Credentials. Where the pharmacy gives Qiri credentials for a program administrator, Qiri stores them encrypted, uses them only for the pharmacy's own claims, and deletes them when the pharmacy revokes them or the Pharmacy Account is closed. An electronic signature or key Health NZ assigns to an individual pharmacist to certify claims is that pharmacist's own, and is used only by that pharmacist or on their express instruction.

    4. Reports. Qiri produces reports on services delivered, by service, by pharmacist and by site, and may email a monthly report to the pharmacy's owner or administrators. These reports are the pharmacy's information and are provided for its own management purposes.

    Schedule 5: Controlled drugs

    1. Scope. Where the controlled drugs module is enabled for your Pharmacy Account, Qiri records the receipt, supply, transfer, destruction, return and counting of controlled drugs within the meaning of the Misuse of Drugs Act 1975 (Controlled Drugs), and of any other medicine your pharmacy chooses to record in the module, and produces the register, reports and other documents your pharmacy asks it to produce. The module is a Paid Service under clause 11.1 and is available only while it is enabled for your Pharmacy Account. It is not available at a site in New Zealand until Qiri states in the product that it is.

    2. Approval in New Zealand. The Misuse of Drugs Regulations 1977 require a pharmacy to keep its controlled drug register and prescription book in the form they prescribe, unless the Director-General of Health has approved another system of recording under regulation 39. That approval is given for a named system. Qiri does not represent that the module is an approved system, and making the module available to your pharmacy is not such an approval. Until Qiri states in the product that the module has been approved, your pharmacy must keep its register in the form the law requires, and may use the module only alongside it. Where Qiri states that the module has been approved, that statement is limited to the approval and the conditions it names, and your pharmacy must use the module in line with them.

    3. The obligations remain your pharmacy's. Every obligation your pharmacy and its people have in relation to Controlled Drugs remains theirs. That includes what must be recorded and by when, who may make or sign an entry, stocktaking and reconciliation, storage, custody and security, destruction and any witness it requires, notification or reporting to an authority, and how long records must be kept. Those obligations rest, as the law that applies to your pharmacy provides, on the pharmacy, on the holder of its licence to operate a pharmacy, on its Responsible Person, on the pharmacist supervising it under section 42A of the Medicines Act 1981 and on the pharmacist on duty. Nothing in the module or in this Agreement transfers any of them to Qiri, and Qiri does not discharge any of them for your pharmacy.

    4. Roles recorded in the product. Where the module records a responsible person, a pharmacist in charge, or a role against a duty, it records what your pharmacy has told it. That record is for your pharmacy's own governance. It is not a determination of who holds an obligation at law, and it does not affect who holds it.

    5. Entries, signatures and access. Entries are made by your Users. An entry made or signed using a User's credentials, including a signing PIN, is that User's act, and Users must not share credentials or PINs. Your pharmacy decides who may access the module, keeps that list current, and is responsible for the accuracy, completeness and timeliness of every entry, count, transfer, destruction and return recorded in it. Qiri does not verify that an entry is correct.

    6. Settings and prompts. The module applies settings taken from the jurisdiction recorded for each of your sites, including entry timing, stocktake frequency, witness requirements, notification periods and similar, and prompts your pharmacy by reference to them. Your pharmacy must keep the jurisdiction recorded for each site correct, and must check those settings and prompts against the law that applies to it. They are settings, not a determination of what the law requires and not legal or regulatory advice, and Qiri may change them as the law changes. Where Qiri identifies a setting as unverified in the product, your pharmacy must not rely on it without checking.

    7. Information about changes in the law. Where Qiri makes available material about the law governing Controlled Drugs, or changes to it, in the product, by email or in a document it generates, that material is general information provided for convenience. It may not be complete, current, or applicable to your pharmacy. It is not legal or regulatory advice, and your pharmacy should obtain its own advice about what it must do.

    8. Notifications to an authority. Qiri does not notify any regulator, health department, police service or other authority on your pharmacy's behalf, and does not make a report of a discrepancy, loss, theft, destruction or outstanding prescription. Where the module prompts that a notification may be required, or records that your pharmacy has made one, that is a record for your pharmacy. It is not the notification, and it is not confirmation that a notification was required, was made, or was made within the time the law allows.

    9. Physical custody and events outside the Platform. Storage, safes, keys and physical custody of Controlled Drugs remain your pharmacy's. Where the module records a count, a destruction, a transfer or a return, it records what the person making the entry has told it. Qiri does not witness, verify or supervise the physical event, and meeting any witness or supervision requirement is your pharmacy's responsibility.

    10. Keeping records when the Platform is unavailable. Your pharmacy must be able to keep the records the law requires at any time the Platform is not available to it, including on paper, and must enter those records in the module when access resumes, recorded as having been made when they were in fact made. Clause 17 applies to the module and Schedule 1 describes the support Qiri provides. The availability of the Platform is not a guarantee that your pharmacy will meet a recording deadline, and must not be relied on as one.

    11. Integrity of the register. A finalised entry cannot be deleted or altered. A correction is made as a further entry, and the module keeps a log of access and activity. Your pharmacy must not attempt to delete, alter or circumvent an entry or a log, and must not make an entry it knows to be false.

    12. Retention, inspection and export. Your pharmacy may export and print the register and its reports at any time, and is responsible for producing records to an inspector or other authorised person and for keeping them for the period the law requires, which continues after this Agreement ends. While your Pharmacy Account is open, Qiri retains register entries, counts, destructions, reviews and the access log and does not delete them. On termination, clause 16.1 governs export and retention, and the register is part of the export described in that clause.

    13. What the module does not do. The module does not decide whether a supply may lawfully be made, does not check a prescriber's authority, permit or approval, and does not connect to or query a real time prescription monitoring system unless Qiri states in the product that it does so for your pharmacy. It does not guarantee that your pharmacy complies with any obligation. Clause 18 applies to anything the module produces.

    14. Risk. Your pharmacy acknowledges that the module is a tool to assist it in keeping records and meeting obligations that remain its own, and that using it is not compliance. Subject to clauses 11.6, 17 and 19, Qiri is not liable for a penalty, fine, enforcement action, licence condition or disciplinary outcome imposed on your pharmacy or its people in connection with an obligation described in paragraph 3.

    Schedule 6: Consult plan

    1. The plan. The Consult plan is a Paid Service plan for a pharmacist, or a business of pharmacists, that delivers consultations as its own practice without operating a pharmacy (your practice). It is charged for each Pharmacist User your practice permits to deliver consultations (a Consulting Pharmacist), and for each Consulting Pharmacist it includes Ask Qiri on the terms of Schedule 2, the consultation features described in Schedule 3, and the professional services and claiming described in Schedule 4 for the programs Qiri makes available on the plan in New Zealand. It does not include dispensing, the controlled drugs module described in Schedule 5, or any other Pharmacy Account feature unless separately subscribed.

    2. Your practice in place of a pharmacy. An Account on the Consult plan is a Pharmacy Account for the purposes of clauses 10, 11.4, 11.7 and 16.1 and Schedules 3 and 4, and in those provisions a reference to a pharmacy or to your pharmacy includes your practice. Your practice therefore controls the records of the consultations its Consulting Pharmacists deliver, and is responsible for everything those provisions give to the pharmacy, including the patient's consent, the lawfulness and scope of the service, its eligibility and accreditation for each program it claims under, and how long records are kept.

    3. Registration and Qiri's check. Each Consulting Pharmacist must be registered with the Pharmacy Council as a pharmacist and hold a current annual practising certificate, and must practise within their scope of practice and any condition on it. When the Consult plan is added to an Account, Qiri asks for the Pharmacy Council registration of the pharmacist who adds it and for your practice's business details, including its New Zealand Business Number, and may check them before it makes bookings, patient records, consultations and Patient Payments available. Qiri may ask for further information. If it is not provided within 14 days of Qiri's request, or Qiri cannot confirm the details, Qiri may withdraw the consultation features. The Account then continues on Ask Qiri Standalone under Schedule 2, and Qiri refunds the part of any Fees already paid that is for the consultation features. When your practice adds a further Consulting Pharmacist it confirms that they hold current registration, and it must tell Qiri promptly if a Consulting Pharmacist's registration or practising certificate lapses, is suspended, is cancelled, or becomes subject to a condition that affects the consultations they deliver.

    4. Users who do not deliver consultations. Your practice may add Users who do not deliver consultations, such as a practice manager or a person who takes bookings, and is not charged for them. Such a User may use Ask Qiri only where your practice's administrator has enabled it for them, and then under the direction of your practice's Consulting Pharmacists, and must not give clinical advice on the strength of it. Paragraph 2 of Schedule 2 applies to them with that exception.

    5. Transcription allowance. For each Consulting Pharmacist the plan includes a monthly allowance of consultation time that Qiri transcribes, whether as live captions or after the consultation, as stated on the Website and in the product. Time is counted once for each consultation, from when transcription starts until it stops. When the allowance is used up, consultations continue, but live captions and transcription stop for that Consulting Pharmacist until the allowance renews at the start of the next month. Unused time does not carry over. A change to the allowance is a change to Fees under clause 11.3.

    6. Consult intelligence. Paragraph 5 of Schedule 3 applies to an Account on the Consult plan as if your practice had enabled consult intelligence, once clause 12.2(c) allows it at a site in New Zealand, and your practice may ask Qiri to switch it off. Qiri produces it only for a consultation where the patient's consent covers analysis of the consultation as well as its recording, and a Pharmacist User may edit or amend anything it produces before adopting it into their note.

    7. The Qiri patient app. Once Qiri has completed its check under paragraph 3, it lists your practice in the Qiri patient app, where patients may find your practice, book and pay for consultations, and join them. Your practice is responsible for the accuracy of its listing and booking information. For consultations delivered in person, Qiri shows the location your practice names, and it does not publish the business address your practice gives Qiri for billing. Your practice is not listed as a pharmacy, and patients cannot send it prescriptions through the app. Your practice may ask Qiri to remove its listing at any time.

    8. Payments, free periods and support. Where your practice takes Patient Payments, clause 11.7 applies. A free period for the Consult plan is offered under clause 11.8, on the terms stated when it is offered. Support for the Consult plan is as described in paragraph 3 of Schedule 2.

    9. Where the plan is offered. The Consult plan is offered in the places Qiri states on the Website, and clause 3.4 applies to a Consulting Pharmacist who practises outside New Zealand.

    Schedule 7: Security

    1. Scope. This Schedule applies to Personal Information Qiri holds for your pharmacy and to the records Qiri hosts for your Pharmacy Account (Pharmacy Data). It is part of Qiri's obligations under clause 15.

    2. Programme. Qiri maintains written information security policies mapped to the Health Information Security Framework (HISO 10029.4), including its guidance for suppliers, with a risk register and a register of its legal and contractual obligations, and completes the supplier risk assessments Health NZ requires for access to Health NZ Systems.

    3. Location and encryption. Pharmacy Data is stored in Australia, in the New Zealand environment clause 12.2(c) describes, and the Privacy Policy lists the providers involved. It is encrypted in transit and at rest. The New Zealand clinical database, its backups and its recovery logs are encrypted with a key Qiri controls and uses only for New Zealand, held in Google Cloud's key management service in Sydney. Identifiers such as the NHI number are also encrypted individually within the database.

    4. Access by Qiri. Qiri gives its personnel access to Pharmacy Data only where their role needs it, through named accounts, and logs that access. Qiri requires its personnel with production access to use a second factor to sign in. Only Qiri personnel located in Australia or New Zealand may access Pharmacy Data, unless Qiri's directors approve an exception in advance after a documented privacy, contractual and security assessment, and Qiri tells your pharmacy, on request, of any exception in place.

    5. Logging. The Platform keeps the audit record clause 10 describes, of clinical decisions, consents, administrative actions and record changes, and a log of access to the controlled drug register. Qiri's operational logs are written so that they carry no patient information.

    6. Testing and vulnerabilities. Qiri applies security updates promptly, protects the Platform's public services with a web application firewall, and has an independent penetration test of the Platform carried out before the Platform first serves a pharmacy in New Zealand, then at least once a year and after a major change, fixing the findings on a timetable set by their severity.

    7. Backup and recovery. Qiri backs up the databases that hold Pharmacy Data at least once a day, keeps at least the last seven daily backups and the logs needed to restore to any point in the last seven days, and stores them in Australia. Qiri's recovery point objective is 24 hours and its recovery time objective is 4 hours, and Qiri tests a restore at least once a year.

    8. Incidents. Qiri responds to a privacy breach as clause 15 describes, keeps a record of every incident affecting Pharmacy Data, and gives your pharmacy the information it needs for its own records and for any notification.

    9. Providers. The providers that store or process Pharmacy Data for Qiri are listed in the Privacy Policy, and each is bound by contract to safeguards comparable to those the Privacy Act and the HIPC require. Qiri will give at least 30 days' notice in the product or by email before a new provider begins to store or process Pharmacy Data outside Australia, and your pharmacy may end this Agreement before the change takes effect if it reasonably objects, with a refund of prepaid Fees for the period after it ends.

    10. Assurance. Once a year, and otherwise on reasonable request, Qiri gives your pharmacy a written summary of the controls in this Schedule and of the most recent penetration test, and answers a reasonable security questionnaire, for example one your pharmacy needs for its own obligations to Health NZ.

    11. Deletion. When Qiri deletes Pharmacy Data under clause 16.1, it deletes it from the live databases, and the copies in its backups are deleted as those backups expire under paragraph 7.

    Schedule 8: NZ Formulary

    1. The content. Where it is enabled, the Platform shows content from the NZ Formulary, such as medicine information, interaction information and label text, which its publisher licenses to Qiri. The content is the publisher's, not Qiri's. Qiri does not write or change it, shows it as it was when retrieved, and records its source.

    2. Use. Your pharmacy and its Users may use NZ Formulary content only through the Platform, at a site in New Zealand, in clinical practice in New Zealand, and for the care of the pharmacy's patients. They must not copy, extract, store, compile or redistribute it, or use it to build or improve another product, except that a record of what was shown with a clinical decision forms part of the pharmacy's records.

    3. Decision support. NZ Formulary content is a reference source behind the Platform's checks, and clause 18 applies to it. It does not replace the Pharmacist User's professional judgement, and Qiri's rule-based checks are not changed by it.

    4. Availability. Qiri's access to NZ Formulary content depends on its licence, which may change or end. If it ends, the content stops being available in the Platform, and clause 3.3 applies as it does to any planned connection.

    Qiri

    Clinical intelligence for community pharmacy.

    Product
    Console Ask Qiri Dispensing & business Controlled drug register Patient app How we compare
    Company
    About Journal Pricing Contact
    Region
    Australia United States New Zealand Global
    Important
    Support Privacy Policy Software User Agreement Patient Terms of Use Trust centre Sources & methodology
    © Qiri 2026. All rights reserved.